 Rafferty Asset Management LLC increased its position in shares of Immunomedics, Inc. NASDAQ:IMMU by 54.8 in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 30,876 shares of the biopharmaceutical companys stock after purchasing an additional 10,933 shares during the period. Rafferty ... 